Total Valuation
Pharmicell Co., Ltd has a market cap or net worth of ₩641.90B. The enterprise value is ―.
Market Cap₩641.90B
Enterprise Value―
Share Statistics
Pharmicell Co., Ltd has 60,004,013 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding60,004,013
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmicell Co., Ltd’s return on equity (ROE) is 0.33 and return on invested capital (ROIC) is 23.45%.
Return on Equity (ROE)0.33
Return on Assets (ROA)0.26
Return on Invested Capital (ROIC)23.45%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee613.23M
Profits Per Employee216.61M
Employee Count186
Asset Turnover0.72
Inventory Turnover4.01
Valuation Ratios
The current PE Ratio of Pharmicell Co., Ltd is 13.5. Pharmicell Co., Ltd’s PEG ratio is 0.04.
PE Ratio13.5
PS Ratio7.65
PB Ratio7.04
Price to Fair Value7.04
Price to FCF25.95
Price to Operating Cash Flow14.43
PEG Ratio0.04
Income Statement
In the last 12 months, Pharmicell Co., Ltd had revenue of 114.06B and earned 40.33B in profits. Earnings per share was 671.97.
Revenue114.06B
Gross Profit50.01B
Operating Income33.78B
Pretax Income34.81B
Net Income40.33B
EBITDA36.81B
Earnings Per Share (EPS)671.97
Cash Flow
In the last 12 months, operating cash flow was 40.63B and capital expenditures -8.68B, giving a free cash flow of 31.95B billion.
Operating Cash Flow40.63B
Free Cash Flow31.95B
Free Cash Flow per Share532.48
Dividends & Yields
Pharmicell Co., Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.73
52-Week Price Change-20.10%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)633.92K
Important Dates
Pharmicell Co., Ltd upcoming earnings date is Aug 19, 2026, TBA (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateAug 19, 2026
Ex-Dividend Date―
Financial Position
Pharmicell Co., Ltd as a current ratio of 4.92, with Debt / Equity ratio of 15.45%
Current Ratio4.92
Quick Ratio4.11
Debt to Market Cap0.02
Net Debt to EBITDA-0.39
Interest Coverage Ratio232.55
Taxes
In the past 12 months, Pharmicell Co., Ltd has paid -5.52B in taxes.
Income Tax-5.52B
Effective Tax Rate-0.16
Enterprise Valuation
Pharmicell Co., Ltd EV to EBITDA ratio is 23.30, with an EV/FCF ratio of 25.53.
EV to Sales7.52
EV to EBITDA23.30
EV to Free Cash Flow25.53
EV to Operating Cash Flow20.89
Balance Sheet
Pharmicell Co., Ltd has ₩60.10B in cash and marketable securities with ₩20.51B in debt, giving a net cash position of ₩39.59B billion.
Cash & Marketable Securities₩60.10B
Total Debt₩20.51B
Net Cash₩39.59B
Net Cash Per Share₩659.71
Tangible Book Value Per Share₩1.97K
Margins
Gross margin is 44.58%, with operating margin of 29.61%, and net profit margin of 35.36%.
Gross Margin44.58%
Operating Margin29.61%
Pretax Margin30.52%
Net Profit Margin35.36%
EBITDA Margin32.27%
EBIT Margin29.61%
Analyst Forecast
The average price target for Pharmicell Co., Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast52.92%
EPS Growth Forecast169.56%